ACS Applied Nano Materials,
Год журнала:
2024,
Номер
7(24), С. 28788 - 28797
Опубликована: Дек. 11, 2024
The
primary
challenges
for
nanozyme-mediated
tumor
catalytic
therapy
are
the
insufficient
activity
of
nanozymes
and
inadequate
endogenous
hydrogen
peroxide
(H2O2)
levels
in
microenvironment
(TME).
To
address
these
challenges,
FeMOF/Pt/GOx
(FMPG),
a
TME-responsive
cascade
nanoreactor,
was
designed
photothermal-cascade
antitumor
therapy.
FMPG
comprises
MIL-100(Fe),
an
iron-based
metal–organic
framework
material,
loaded
with
ultrasmall
platinum
nanoparticles
(Pt
NPs)
glucose
oxidase
(GOx).
Within
TME,
degrades
presence
high
phosphate
concentrations,
releasing
GOx,
Fe2+,
Pt
NPs.
GOx
consumes
glucose,
reducing
ATP
cells
inducing
starvation
state
cells.
Subsequently,
H2O2
produced
by
overexpressed
reacts
Fe2+
to
generate
hydroxyl
radicals,
facilitating
NPs
exhibit
catalase-like
catalyze
production
oxygen
from
H2O2,
further
enhancing
starvation.
Under
808
nm
laser
irradiation,
as-prepared
composites
localized
heat,
enabling
effective
photothermal
This
nanoreactor
demonstrates
efficient
inhibition
situ
consumption
compounds,
promoting
development
precise
synergetic
cancer
therapies
spatiotemporal
controllability.
Chemical Reviews,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 27, 2025
Nanozymes
have
shown
significant
potential
in
cancer
catalytic
therapy
by
strategically
catalyzing
tumor-associated
substances
and
metabolites
into
toxic
reactive
oxygen
species
(ROS)
situ,
thereby
inducing
oxidative
stress
promoting
cell
death.
However,
within
the
complex
tumor
microenvironment
(TME),
rational
design
of
nanozymes
factors
like
activity,
reaction
substrates,
TME
itself
significantly
influence
efficiency
ROS
generation.
To
address
these
limitations,
recent
research
has
focused
on
exploring
that
affect
activity
developing
nanozyme-based
cascade
systems,
which
can
trigger
two
or
more
processes
tumors,
producing
therapeutic
achieving
efficient
stable
with
minimal
side
effects.
This
area
remarkable
progress.
Perspective
provides
a
comprehensive
overview
nanozymes,
covering
their
classification
fundamentals.
The
regulation
nanozyme
strategies
are
discussed
detail.
Furthermore,
representative
paradigms
for
successful
construction
systems
treatment
summarized
focus
revealing
underlying
mechanisms.
Finally,
we
current
challenges
future
prospects
development
biomedical
applications.
Microplastics,
as
an
emerging
environmental
pollutant,
have
received
widespread
attention
for
their
potential
impact
on
ecosystems
and
human
health.
Microplastics
are
defined
plastic
particles
less
than
5
millimeters
in
diameter
can
be
categorized
primary
secondary
microplastics.
Primary
microplastics
usually
originate
directly
from
industrial
production,
while
formed
by
the
degradation
of
larger
items.
capable
triggering
cytotoxicity
chronic
inflammation,
may
promote
cancer
through
mechanisms
such
pro-inflammatory
responses,
oxidative
stress
endocrine
disruption.
In
addition,
improved
bring
new
perspectives
to
therapy,
studies
drug
carriers
underway,
showing
high
targeting
bioavailability.
Although
current
suggest
association
between
certain
cancers
(e.g.,
lung,
liver,
breast
cancers),
long-term
effects
specific
still
need
studied.
This
review
aimed
at
exploring
carcinogenicity
promising
applications
therapy
provides
important
directions
future
research
emphasizes
multidisciplinary
collaboration
address
this
global
health
challenge.
Journal of Nanobiotechnology,
Год журнала:
2025,
Номер
23(1)
Опубликована: Фев. 20, 2025
The
advent
of
nanozymes
has
revolutionized
approaches
to
cancer
diagnosis
and
therapy,
introducing
innovative
strategies
that
address
the
limitations
conventional
treatments.
Nanozyme
nanostructures
with
enzyme-mimicking
catalytic
abilities
exhibit
exceptional
stability,
biocompatibility,
customizable
functions,
positioning
them
as
promising
tools
for
theranostics.
By
emulating
natural
enzyme
reactions,
can
selectively
target
eradicate
cells,
minimizing
harm
adjacent
healthy
tissues.
Nanozymes
also
be
functionalized
specific
targeting
ligands,
allowing
precise
delivery
regulated
release
therapeutic
agents,
improving
treatment
effectiveness
reducing
adverse
effects.
However,
issues
such
selectivity,
regulatory
compliance
remain
critical
challenges
clinical
application
nanozymes.
This
review
provides
an
overview
nanozymes,
highlighting
their
unique
properties,
various
classifications,
activities,
diverse
applications
in
strategic
oncological
deployment
could
profoundly
impact
future
advancements
personalized
medicine,
recent
progress
prospective
directions
enzyme-mimetic
treatment.
summarizes
Abstract
Immunotherapy
represents
a
widely
employed
modality
in
clinical
oncology,
leveraging
the
activation
of
human
immune
system
to
target
and
eradicate
cancer
cells
tumor
tissues
via
endogenous
mechanisms.
However,
its
efficacy
remains
constrained
by
inadequate
responses
within
“cold”
microenvironment
(TME).
In
this
study,
multifunctional
nanoscale
pyroptosis
inducer
with
cascade
enzymatic
activity
(IMZF),
comprising
superoxide
dismutase
(SOD),
catalase
(CAT),
peroxidase
(POD),
glutathione
oxidase
(GSHO
x
),
is
dissociated
acidic
glutathione‐rich
TME.
The
vigorous
not
only
generates
oxygen
(O
2
)
alleviate
hypoxia
promote
M2
M1
macrophage
polarization
but
also
yields
reactive
species
(ROS)
depletes
(GSH)
Functioning
as
an
immunogenic
cell
death
(ICD)
activator
inducer,
IMZF
synergistically
triggers
dendritic
maturation
inflammatory
lymphocyte
infiltration
ICD‐associated
pyroptosis,
thereby
reversing
suppression
TMEs.
Consequently,
it
exerts
inhibitory
effects
on
both
primary
distal
tumors.
This
platform‐based
offers
intelligent
strategy
for
effectively
overcoming
tumors,
providing
promising
avenue
advanced
immunotherapeutic
interventions.
Polyoxometalates,
Год журнала:
2025,
Номер
4(1), С. 9140074 - 9140074
Опубликована: Март 1, 2025
In
recent
years,
polyoxometalates
have
been
systematically
studied
in
the
treatment
of
diabetes,
tumor,
cancer,
inflammation
and
other
diseases
vitro
vivo,
their
main
therapeutic
mechanisms
are
related
to
generation
reactive
oxygen
species
causing
oxidative
stress.
The
site
production
is
mitochondria,
therefore,
mechanism
may
be
mitochondrial
biosynthesis.
This
paper
describes
one
diabetes
mellitus,
which
involves
increase
species,
resulting
stress;
at
same
time,
preliminarily
as
antioxidants
antitumor
mellitus
tumors,
antioxidant
properties
provide
an
additional
possibility
for
future
a
drug
disease
treatment;
on
basis
study
stress
biomolecule
due
it,
associating
therapy
actually
closely
through
biosynthesis
regulation
relationship
between
mitochondria
its
impact
three
aspects
order
in-depth
role
drugs
aspects.
ACS Applied Nano Materials,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 2, 2025
Recently,
metal
peroxides
with
the
ability
to
self-supply
H2O2
have
been
intensively
used
in
antibacterial
and
cancer
therapy.
However,
performances
are
unsatisfactory
due
low
efficiency
of
peroxide-mediated
Fenton-like
reaction.
In
this
work,
a
novel
zinc
cerium
bimetallic
peroxide
(CeZnOx)
has
first
reported,
which
possesses
acid-activated
POD-like,
OXD-like,
CAT-like
multienzymatic
activities
for
efficiently
bacterial
inhibition.
Specifically,
CeZnOx
self-supplying
under
weakly
acidic
conditions
subsequently
catalyzes
production
reactive
oxygen
species
(ROS)
through
synergistically
enhanced
POD-like
OXD-like
activity.
They
can
also
exhibit
activity
catalyze
excessive
into
O2
play
an
anti-inflammatory
role
normal
pH
conditions.
The
cascade
inhibit
growth
alleviate
hypoxia,
improving
microenvironment
at
wound
site.
As
expected,
exhibits
superior
effect
on
Staphylococcus
aureus
Escherichia
coli.
Therefore,
CeZnOx-mediated
offer
simple
promising
strategy
efficient
treatment
infections.
Advanced Functional Materials,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 21, 2025
Abstract
Tumor
cells
exploit
abnormal
redox
homeostasis
and
the
pro‐tumorigenic
effect
of
reactive
oxygen
species
(ROS)
to
enhance
their
survival
progression.
However,
excessively
high
levels
ROS
can
exceed
oxidative
stress
threshold
tumor
cells,
inducing
cell
death.
This
occur
by
selectively
elevating
concentration
H
2
O
in
through
both
endogenous
exogenous
mechanisms.
The
generated
serves
as
a
precursor
for
toxic
ROS,
such
•
OH
1
,
via
chemodynamic
photodynamic
therapy,
respectively,
leading
apoptosis,
necrosis,
ferroptosis.
Strategies
boost
include
direct
delivery
amplifying
generation
inhibiting
antioxidant
enzymes,
leveraging
glucose
oxidase,
employing
photocatalytic
therapy
(PCT),
utilizing
metal
peroxides.
Among
them,
peroxides
have
displayed
remarkable
performance
due
excellent
potential
elevate
within
while
simultaneously
normalizing
acidic
hypoxic
conditions
microenvironment
(TME).
Moreover,
these
nanostructures
sensitivity
complementary
treatments,
like
chemotherapy.
review
summarizes
advanced
perspectives
design,
synthesis,
comparative
analysis
‐generating
nanoplatforms,
emphasizing
capacity
treat
various
cancers.
Pharmaceutics,
Год журнала:
2025,
Номер
17(4), С. 448 - 448
Опубликована: Март 31, 2025
Background:
Prostate
cancer
(PCa)
is
the
second
most
prevalent
in
males
globally,
impacting
one
out
of
every
six
males.
However,
therapeutic
effect
chemotherapy
on
PCa
restricted.
Methods:
To
address
this,
we
developed
a
tumor-targeted
multifunctional
liposomal
platform
(PTX-PS/Zn@Lip-Apt)
for
zinc-enhanced
chemo-photodynamic
therapy
PCa.
Co-delivery
PTX
and
an
aggregation-induced
emission
photosensitizer
(TPEDPD)
enables
combined
photody-namic
therapy.
Zinc
ions
were
loaded
into
liposomes
to
improve
chemosensitivity
chemodrugs.
Then,
AS1411
aptamer
was
further
modified
onto
sur-face
liposome
enhance
its
tumor
targeting
ability.
Moreover,
cellular
uptake
efficiency
nanoparticles,
photochemical
internalization
(PCI)
strategy
also
employed.
Results:
In
vitro
experiments
indicated
that
conjugation
PCI
application
enhanced
cytotoxicity
PTX/PS-Zn@Lip-Apt.
The
zinc
ion
could
be
found.
vivo
demonstrated
good
antitumor
biosafety
Conclusions:
Our
findings
provide
important
basis
innovatively
applying
prostate
cancer.
Research Square (Research Square),
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 7, 2025
Abstract
RNA-based
therapies,
especially
small
interfering
RNA
(siRNA),
have
attracted
extensive
attention
for
tumor
treatment.
However,
most
siRNA
can’t
exert
a
therapeutic
effect
due
to
lack
of
targeting
cells
and
entrapment
in
lysosomes
upon
administration.
To
address
the
challenges
associated
with
delivery,
delivery
system
was
developed
using
zinc
oxide
nanoparticles
(ZnO
NPs)
coated
cancer
cell
membranes.
ZnO
been
recognized
as
effective
pH-responsive
are
widely
used
development
drug
systems
pH-responsive.
The
NPs
were
combined
chitosan
encapsulate
siRNA,
allowing
dissolution
acidic
subsequent
release
complexes.
would
also
disrupt
lysosomes,
facilitating
escape
enhancing
its
gene
silencing
effect.
nano-complexes
(CS/ZnO@iRNA)
unstable
solution
lacked
specific
cells.
Thus,
homologous
membrane
onto
nanoparticles,
which
has
shown
be
an
strategy
their
stability
capabilities.
Moreover,
not
only
dissolve
enhance
efficacy
but
elevate
oxidative
stress
levels
cells,
leading
induction
cellular
apoptosis.
It
demonstrated
both
in
vitro
vivo
that
could
synergistically
combine
anti-tumor
(siSurvivin)
inhibit
growth
4T1
tumor.
Altogether,
(CCM-CS/ZnO@siSurvivin)
offers
new
while
inhibiting
growth.